SAB BIOTHERAPEUTICS, INC.

Follow

Organization

SIOUX FALLS, SD, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Ungulate-derived polyclonal immunoglobulin specific for coronavirus...
- Patent number 11,975,066
- Issue date May 7, 2024
- SAB Biotherapeutics, Inc.
- Tom Luke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
UNGULATE-DERIVED POLYCLONAL IMMUNOGLOBULIN SPECIFIC FOR CORONAVIRUS...
- Publication number 20240374704
- Publication date Nov 14, 2024
- SAB Biotherapeutics, Inc.
- Tom LUKE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
UNGULATE-DERIVED POLYCLONAL IMMUNOGLOBULIN SPECIFIC FOR CORONAVIRUS...
- Publication number 20220062405
- Publication date Mar 3, 2022
- SAB Biotherapeutics, Inc.
- Tom LUKE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Systems and Methods for the Production of Human Polyclonal Antibodies
- Publication number 20170233459
- Publication date Aug 17, 2017
- SAB Biotherapeutics, Inc.
- Jay Hooper
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Trademarklast 30 trademarks